ANXA5 and myocardial infarction: Treatment with exogenous ANXA5 reveals that labeled ANXA5 accumulates in a punctate pattern in the infarcted area, which is significantly reduced in the infarcted area of myocardial infarction after 3 weeks (de Jong et al., 2018).